CUFinder

Franziska Briest

About Franziska Briest

Franziska Briest, With an exceptional h-index of 11 and a recent h-index of 10 (since 2020), a distinguished researcher at Charité - Universitätsmedizin Berlin, specializes in the field of neuroendocrine Tumors, cancer Research, molecular medicine, lymphoma, signal transduction.

His recent articles reflect a diverse array of research interests and contributions to the field:

Concomitant inhibition of PI3K/mTOR signaling pathways boosts antiproliferative effects of lanreotide in bronchopulmonary neuroendocrine tumor cells

Genetic characterization of primary mediastinal B-cell lymphoma: pathogenesis and patient outcomes

Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma

S101: GENETIC AND EPIGENETIC FACTORS DRIVING PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATHOGENESIS AND OUTCOME

Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9

Abstract LBA043: mRNA expression of mTOR signaling components as potential predictive biomarker in pancreatic neuroendocrine neoplasms

A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: results from the CONKO-005 trial

Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms?–A preclinical assessment in vitro and in vivo

Franziska Briest Information

University

Position

___

Citations(all)

370

Citations(since 2020)

209

Cited By

226

hIndex(all)

11

hIndex(since 2020)

10

i10Index(all)

13

i10Index(since 2020)

10

Email

University Profile Page

Google Scholar

Franziska Briest Skills & Research Interests

neuroendocrine Tumors

cancer Research

molecular medicine

lymphoma

signal transduction

Top articles of Franziska Briest

Concomitant inhibition of PI3K/mTOR signaling pathways boosts antiproliferative effects of lanreotide in bronchopulmonary neuroendocrine tumor cells

Frontiers in Pharmacology

2024/2/5

Franziska Briest
Franziska Briest

H-Index: 7

Genetic characterization of primary mediastinal B-cell lymphoma: pathogenesis and patient outcomes

Journal of Clinical Oncology

2024/2/1

Franziska Briest
Franziska Briest

H-Index: 7

Kenichi Yoshida
Kenichi Yoshida

H-Index: 14

Thomas Weber
Thomas Weber

H-Index: 2

Naveed Ishaque
Naveed Ishaque

H-Index: 20

Lars Bullinger
Lars Bullinger

H-Index: 62

Pier Luigi Zinzani
Pier Luigi Zinzani

H-Index: 67

Theodoros P Vassilakopoulos
Theodoros P Vassilakopoulos

H-Index: 23

Frederik Damm
Frederik Damm

H-Index: 25

Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma

Leukemia

2023/11

Franziska Briest
Franziska Briest

H-Index: 7

Kenichi Yoshida
Kenichi Yoshida

H-Index: 14

Penelope Korkolopoulou
Penelope Korkolopoulou

H-Index: 28

Ákos Nagy
Ákos Nagy

H-Index: 3

Lars Bullinger
Lars Bullinger

H-Index: 62

Theodoros P Vassilakopoulos
Theodoros P Vassilakopoulos

H-Index: 23

Frederik Damm
Frederik Damm

H-Index: 25

S101: GENETIC AND EPIGENETIC FACTORS DRIVING PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATHOGENESIS AND OUTCOME

HemaSphere

2022/6

Franziska Briest
Franziska Briest

H-Index: 7

Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9

Leukemia

2022/4

Lars Bullinger
Lars Bullinger

H-Index: 62

Franziska Briest
Franziska Briest

H-Index: 7

Frederik Damm
Frederik Damm

H-Index: 25

Abstract LBA043: mRNA expression of mTOR signaling components as potential predictive biomarker in pancreatic neuroendocrine neoplasms

Molecular Cancer Therapeutics

2021/12/1

Franziska Briest
Franziska Briest

H-Index: 7

Malte Buchholz
Malte Buchholz

H-Index: 24

A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: results from the CONKO-005 trial

EBioMedicine

2021/4/1

Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms?–A preclinical assessment in vitro and in vivo

Neoplasia

2021/1/1

Franziska Briest
Franziska Briest

H-Index: 7

Christian Fischer
Christian Fischer

H-Index: 9

Carsten Grötzinger
Carsten Grötzinger

H-Index: 15

Immunoprofiling in neuroendocrine neoplasms unveil immunosuppressive microenvironment

Cancers

2020/11/19

Franziska Briest
Franziska Briest

H-Index: 7

See List of Professors in Franziska Briest University(Charité - Universitätsmedizin Berlin)

Co-Authors

academic-engine

Useful Links

List of top 50 universities
List of top 100 universities
List of top 500 universities
Find Professors Email
Find Universities Email
CUFinder Academic Engine